Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3, S152-S157
- https://doi.org/10.3816/cbc.2003.s.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Generation of T-Cell Immunity to the HER-2/neu Protein After Active Immunization With HER-2/neu Peptide–Based VaccinesJournal of Clinical Oncology, 2002
- Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu–overexpressing cancersBlood, 2002
- Immunotherapy of multiple myelomaSeminars in Hematology, 2001
- Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancerBone Marrow Transplantation, 2000
- High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in CaliforniaTransplantation and Cellular Therapy, 2000
- Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccineBone Marrow Transplantation, 2000
- Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.Journal of Clinical Investigation, 1997
- A Phase I Trial of a Synthetic Mucin Peptide VaccineJournal of Surgical Research, 1996
- Antiidiotype Induction Therapy: Evidence for the Induction of Immune Response through the Idiotype Network in Patients with Ovarian Cancer after Administration of Anti-CA 125 Murine Monoclonal Antibody B43.13Hybridoma, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958